These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 32498976)

  • 21. The potential of biomarkers of fibrosis in chronic lung allograft dysfunction.
    van der Ploeg EA; Melgert BN; Burgess JK; Gan CT
    Transplant Rev (Orlando); 2021 Jul; 35(3):100626. PubMed ID: 33992914
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Restrictive allograft syndrome (RAS): a novel form of chronic lung allograft dysfunction.
    Sato M; Waddell TK; Wagnetz U; Roberts HC; Hwang DM; Haroon A; Wagnetz D; Chaparro C; Singer LG; Hutcheon MA; Keshavjee S
    J Heart Lung Transplant; 2011 Jul; 30(7):735-42. PubMed ID: 21419659
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic lung allograft dysfunction after lung transplantation: the moving target.
    Sato M
    Gen Thorac Cardiovasc Surg; 2013 Feb; 61(2):67-78. PubMed ID: 23138970
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neutrophilic reversible allograft dysfunction (NRAD) and restrictive allograft syndrome (RAS).
    Verleden SE; Vandermeulen E; Ruttens D; Vos R; Vaneylen A; Dupont LJ; Van Raemdonck DE; Vanaudenaerde BM; Verleden GM
    Semin Respir Crit Care Med; 2013 Jun; 34(3):352-60. PubMed ID: 23821509
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative Image Analysis at Chronic Lung Allograft Dysfunction Onset Predicts Mortality.
    Weigt SS; Kim GJ; Jones HD; Ramsey AL; Amubieya O; Abtin F; Pourzand L; Lee J; Shino MY; DerHovanessian A; Stripp B; Noble PW; Sayah DM; Saggar R; Britton I; Lynch JP; Belperio JA; Goldin J
    Transplantation; 2022 Jun; 106(6):1253-1261. PubMed ID: 34534193
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phenotyping CLAD after single lung transplant: Limits and prognostic assessment of the 2019 ISHLT classification system.
    Berra G; Huszti E; Levy L; Kawashima M; Fuchs E; Renaud-Picard B; Riddell P; Dias O; Rajagopala S; Ulahannan A; Ghany R; Singer LG; Tikkanen J; Martinu T
    J Heart Lung Transplant; 2022 May; 41(5):599-607. PubMed ID: 35351385
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low-dose computed tomography volumetry for subtyping chronic lung allograft dysfunction.
    Saito T; Horie M; Sato M; Nakajima D; Shoushtarizadeh H; Binnie M; Azad S; Hwang DM; Machuca TN; Waddell TK; Singer LG; Cypel M; Liu M; Paul NS; Keshavjee S
    J Heart Lung Transplant; 2016 Jan; 35(1):59-66. PubMed ID: 26342441
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic Lung Allograft Dysfunction.
    Venado A; Kukreja J; Greenland JR
    Thorac Surg Clin; 2022 May; 32(2):231-242. PubMed ID: 35512941
    [TBL] [Abstract][Full Text] [Related]  

  • 29. When tissue is the issue: A histological review of chronic lung allograft dysfunction.
    Verleden SE; Von der Thüsen J; Roux A; Brouwers ES; Braubach P; Kuehnel M; Laenger F; Jonigk D
    Am J Transplant; 2020 Oct; 20(10):2644-2651. PubMed ID: 32185874
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MRI-derived regional flow-volume loop parameters detect early-stage chronic lung allograft dysfunction.
    Moher Alsady T; Voskrebenzev A; Greer M; Becker L; Kaireit TF; Welte T; Wacker F; Gottlieb J; Vogel-Claussen J
    J Magn Reson Imaging; 2019 Dec; 50(6):1873-1882. PubMed ID: 31134705
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic lung allograft dysfunction phenotype and prognosis by machine learning CT analysis.
    McInnis MC; Ma J; Karur GR; Houbois C; Levy L; Havlin J; Fuchs E; Tikkanen J; Chow CW; Huszti E; Martinu T
    Eur Respir J; 2022 Jul; 60(1):. PubMed ID: 34949699
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic lung allograft dysfunction: evolving practice.
    Vos R; Verleden SE; Verleden GM
    Curr Opin Organ Transplant; 2015 Oct; 20(5):483-91. PubMed ID: 26262458
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative chest CT for subtyping chronic lung allograft dysfunction and its association with survival.
    Horie M; Salazar P; Saito T; Binnie M; Brock K; Yasufuku K; Azad S; Keshavjee S; Martinu T; Paul N
    Clin Transplant; 2018 May; 32(5):e13233. PubMed ID: 29637624
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The accuracy of forced vital capacity for diagnosing restrictive allograft syndrome and mixed phenotype of chronic lung allograft dysfunction.
    Levy L; Huszti E; Berra G; Renaud-Picard B; Kawashima M; Takahagi A; Moshkelgosha S; Ghany R; Fuchs E; Chow CW; Keshavjee S; Singer LG; Tikkanen J; Martinu T
    Eur Respir J; 2021 Jul; 58(1):. PubMed ID: 34172465
    [No Abstract]   [Full Text] [Related]  

  • 35. Chronic Lung Allograft Dysfunction: Evolving Concepts and Therapies.
    DerHovanessian A; Wallace WD; Lynch JP; Belperio JA; Weigt SS
    Semin Respir Crit Care Med; 2018 Apr; 39(2):155-171. PubMed ID: 29579768
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Validation and Refinement of Chronic Lung Allograft Dysfunction Phenotypes in Bilateral and Single Lung Recipients.
    DerHovanessian A; Todd JL; Zhang A; Li N; Mayalall A; Finlen Copeland CA; Shino M; Pavlisko EN; Wallace WD; Gregson A; Ross DJ; Saggar R; Lynch JP; Belperio J; Snyder LD; Palmer SM; Weigt SS
    Ann Am Thorac Soc; 2016 May; 13(5):627-35. PubMed ID: 27144793
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of recipient derived interleukin-17A in a murine orthotopic lung transplant model of restrictive chronic lung allograft dysfunction.
    Yamada Y; Vandermeulen E; Heigl T; Somers J; Vaneylen A; Verleden SE; Bellon H; De Vleeschauwer S; Verbeken EK; Van Raemdonck DE; Vos R; Verleden GM; Jungraithmayr W; Vanaudenaerde BM
    Transpl Immunol; 2016 Nov; 39():10-17. PubMed ID: 27737799
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapy options for chronic lung allograft dysfunction-bronchiolitis obliterans syndrome following first-line immunosuppressive strategies: A systematic review.
    Benden C; Haughton M; Leonard S; Huber LC
    J Heart Lung Transplant; 2017 Sep; 36(9):921-933. PubMed ID: 28662986
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of biomechanical anatomical modeling via computed tomography for identification of restrictive allograft syndrome.
    Horie M; Saito T; Moseley J; D'Errico L; Salazar P; Nakajima D; Brock K; Yasufuku K; Binnie M; Keshavjee S; Paul N
    Clin Transplant; 2017 Aug; 31(8):. PubMed ID: 28658530
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Lymphatic Phenotype of Lung Allografts in Patients With Bronchiolitis Obliterans Syndrome and Restrictive Allograft Syndrome.
    Traxler D; Schweiger T; Schwarz S; Schuster MM; Jaksch P; Lang G; Birner P; Klepetko W; Ankersmit HJ; Hoetzenecker K
    Transplantation; 2017 Feb; 101(2):310-315. PubMed ID: 27163544
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.